Retraction Watch

Tracking retractions as a window into the scientific process

Archive for the ‘austria’ Category

Retractions follow revelations of misconduct by diabetes biotech

with 3 comments

diabetes careSeveral months after a drug company cancelled development of a potential diabetes cure because it found evidence that a biotech they had recently acquired had committed misconduct in studies of the drug, two retractions of relevant studies have appeared.

The research involves DiaPep277, which, as Josh Levy explained here in September, “would cause the immune system to stop attacking beta cells,” the cells in the pancreas that produce insulin. But Hyperion Therapeutics, which had acquired DiaPep277 developer Andromeda Biotech in June, announced in September that it had

uncovered evidence that certain employees of Andromeda Biotech, Ltd., which Hyperion acquired in June 2014, engaged in serious misconduct, including collusion with a third-party biostatistics firm in Israel to improperly receive un-blinded DIA-AID 1 trial data and to use such data in order to manipulate the analyses to obtain a favorable result.

The retractions are both of papers published in Diabetes Care in May 2014. Here’s the notice for “Treatment of Recent-Onset Type 1 Diabetic Patients With DiaPep277: Results of a Double-Blind, Placebo-Controlled, Randomized Phase 3 Trial:” Read the rest of this entry »

Phantom authorship forces retraction of electron paper

with one comment

ULTRAMICUltramicroscopy has retracted a paper it published earlier this year after the corresponding author admitted to submitting the paper without the consent of his colleagues.

The article, “The post-peak spectra in electron energy loss near edge structure,” came from a group led by one Feng Tian, a materials scientist at Shanghai University for Science and Technology. The other authors were Peter Shattschneider and Micheal Stoger-Pollach, of the Vienna University of Technology. Except that they weren’t.

According to the retraction notice: Read the rest of this entry »

Written by amarcus41

December 8th, 2014 at 9:30 am

Cardiology researcher who admitted to fraud earns four-year funding ban

with 6 comments

dfg_logoA researcher who admitted in 2012 to “intentional and systematic manipulation” of data and had two papers retracted has been banned from funding by the German Research Foundation (DFG).

Dennis Rottländer, who will also be returning prize money he was awarded for the research, worked in Uta C. Hoppe’s lab at the University of Cologne. Hoppe, now at University Hospital Salzburg, remains under investigation, according to a statement from the DFG.

Excerpt: Read the rest of this entry »

A partial retraction appears for former Salzburg crystallographer who admitted misconduct

with 8 comments

j imm april 2013A paper by a crystallographer fired from his university for misconduct has been partially retracted.

Last year, we covered the case of Robert Schwarzenbacher, formerly of Salzburg University. Schwarzenbacher had provided the crystallographic data for a paper in the Journal of Immunology, but those results raised questions with another crystallographer and prompted an investigation by the university.  Schwarzenbacher admitted he’d committed misconduct, although he recanted at one point, and was eventually fired.

Now, the authors have retracted the crystallographic data from the Journal of Immunology paper. Here’s the partial retraction, which is listed as a correction:
Read the rest of this entry »

Retraction for water researchers who ripped off dissertation

without comments

JCAMcoverA pair of engineers at Hohai University in Nanjing, China, has lost their 2012 paper in the Journal of Computational and Applied Mathematics. The reason: The article, “Study of the New Leon model for concrete failure,” wasn’t theirs to publish.

According to the retraction notice (which is dated September 2013 but has already appeared in ScienceDirect): Read the rest of this entry »

Paper — with longest title ever? — retracted for lack of author approval

without comments

inorgchimactaThe journal Inorganica Chimica Acta has retracted a paper it published earlier this year over an authorship dispute involving the lead researcher and his colleagues in France.

The title of the paper — whose bulk alone gave us a headache  — was “Reaction of a bidentate ligands (4,4′-dimethyl 2,2′-bipyridine) with planar-chiral chloro-bridged ruthenium: Synthesis of cis-dicarbonyl[4,4′-dimethyl-2,2′-bipyridine- κO1,κO2]{2-[tricarbonyl(η6-phenylene- κC1)chromium]pyridine-κN}ruthenium hexafluorophosphate” — and it purportedly came from a lab in Beirut.

However, as the retraction notice indicates, that’s not quite so:

Read the rest of this entry »

Not in my journal: Two editors take stock of misconduct in their fields — and don’t find much

with 11 comments

biol conservToday brings two journal editorials about misconduct and retractions. They take, if we may, a bit of an optimistic and perhaps even blindered approach.

In an editorial titled “Scientific misconduct occurs, but is rare,” Boston University’s Richard Primack, editor of Biological Conservation, highlights a Corrigendum of a paper by Jesus Angel Lemus, the veterinary researcher who has retracted seven papers: Read the rest of this entry »

A different tack: A “notice of redundant publication,” rather than a retraction, for duplication

with 6 comments

bjogHow should journals deal with duplication — aka “self-plagiarism?”

Scientists have engaged in vigorous debates here on Retraction Watch about whether such duplication is a minor form of scientific misconduct, or just a conflict between the interests of publishers and those of researchers who have better things to do than figure out different ways to describe their materials and methods.

So we thought we’d highlight how an obstetrics and gynecology journal recently handled a six-year-old duplication. Here’s the “notice of redundant publication:” Read the rest of this entry »

Written by Ivan Oransky

December 21st, 2012 at 1:00 pm

Two patch-clamping retractions in PNAS and the JCI after first author admits image manipulation

with 17 comments

jci1212A group of cardiology researchers formerly of the University of Cologne has retracted two papers, after investigations into allegations of misconduct led to an admission of guilt by one of the lab’s junior members.

Here’s the first retraction, for “Connexin 43 acts as a cytoprotective mediator of signal transduction by stimulating mitochondrial KATP channels in mouse cardiomyocytes,” published last week in the Journal of Clinical Investigation: Read the rest of this entry »

Make it a double: Alcohol treatment study pulled for duplication

without comments

European Child & Adolescent Psychiatry has retracted a 2003 paper on the treatment of alcoholism for a vague “copyright violation.” But the reason appears to be that the article was largely identical to a 2002 report from one of the authors and other colleagues.

The offending paper, “Acamprosate and its efficacy in treating alcohol dependent adolescents,” appeared in June 2003 and has been cited 51 times, according to Google Scholar. The authors were Helmut Niederhofer and Wolfgang Staffen, of the Christian Doppler-Klinik, in Salzburg.

According to the rather uninformative notice: Read the rest of this entry »